annualising that rate you get 46.4%. Thats pretty significant growth. Hopefully they can put off a cap raising till q1 2016 but a cap raising before long looks pretty likely. That was always going to be the case until they find a vaccine partner, its just a little sooner than expected. The reason I hope they can delay it is that we might get into another cardiocel market or something else before then. Everything now depends on the half yearly - perhaps when we take into account receivables, we won't need a cap raise till the end of the calendar year.
$1 mill for cardiocel must mean that there is some solid demand out there
annualising that rate you get 46.4%. Thats pretty significant...
-
- There are more pages in this discussion • 84 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.14 |
Change
0.000(0.00%) |
Mkt cap ! $277.7M | |||
| Open | High | Low | Value | Volume |
| $13.33 | $13.91 | $13.14 | $302.2K | 22.46K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 299 | $13.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.49 | 35 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |